Coronary artery bypass grafting in 105 patients with hemodialysis-dependent renal failure

H Nishida1, S Uchikawa, G Chikazawa

  • 1Department of Cardiovascular Surgery, The Heart Institute of Japan, Tokyo Women's Medical University, Tokyo, Japan. snishida@hij.twmu.ac.jp

Artificial Organs
|April 25, 2001
PubMed

Insights

Coronary artery bypass grafting (CABG) in dialysis patients shows high mortality but offers better long-term survival than general dialysis patients. Meticulous perioperative care is crucial for improving outcomes in these high-risk cardiac surgery patients.

Area of Science:

  • Cardiology
  • Nephrology
  • Cardiac Surgery

Background:

  • Dialysis-dependent renal failure (RF) patients represent a high-risk group for cardiovascular procedures.
  • Coronary artery bypass grafting (CABG) outcomes in this specific population require detailed evaluation.
  • Understanding preoperative characteristics is vital for risk stratification and management.

Purpose of the Study:

  • To define the early and long-term results of CABG in patients with end-stage renal disease on maintenance dialysis.
  • To analyze preoperative patient characteristics influencing CABG outcomes in this cohort.
  • To compare long-term survival in these patients with the general dialysis population.

Main Methods:

  • Retrospective analysis of 105 dialysis-dependent RF patients undergoing isolated CABG between 1985 and 2000.
  • Inclusion criteria: maintenance dialysis (hemodialysis or peritoneal dialysis).
  • Data collected included preoperative comorbidities, surgical details, and postoperative outcomes, with 100% follow-up averaging 3.1 years.

Main Results:

  • Early mortality (within 30 days) was 4.8%, with cardiac deaths linked to circulatory collapse during hemodialysis in patients with severe left ventricular dysfunction.
  • Late mortality before discharge was 7.6% (noncardiac).
  • Five-year actuarial survival was 59.8%; cardiac death-free and event-free rates were 83.0% and 62.4%, respectively. Arterial conduits were used in 97% of patients.

Conclusions:

  • CABG in dialysis-dependent RF patients is associated with significant early and long-term mortality, influenced by preoperative condition severity.
  • Despite high mortality, long-term survival post-CABG remains superior to that of the general dialysis population.
  • Meticulous perioperative management is identified as a key factor for improving early surgical results in this vulnerable group.

Related Concept Videos

Dialysis01:15

Dialysis

Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...